Compare KE & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KE | IART |
|---|---|---|
| Founded | 1961 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.4M | 867.7M |
| IPO Year | N/A | 1995 |
| Metric | KE | IART |
|---|---|---|
| Price | $30.67 | $11.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | ★ $28.00 | $15.00 |
| AVG Volume (30 Days) | 147.1K | ★ 691.5K |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.88 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | $1,478,074,000.00 | ★ $1,642,966,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | $4.70 | $2.71 |
| P/E Ratio | $32.34 | ★ N/A |
| Revenue Growth | N/A | ★ 4.99 |
| 52 Week Low | $12.41 | $10.65 |
| 52 Week High | $33.19 | $26.98 |
| Indicator | KE | IART |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 39.28 |
| Support Level | $28.93 | $10.65 |
| Resistance Level | $31.61 | $11.64 |
| Average True Range (ATR) | 1.28 | 0.49 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 54.23 | 19.49 |
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.